Projects per year
Personal profile
Research expertise
Bouke de Jong completed her training in clinical infectious diseases at the Universities of Amsterdam, Nevada, and Stanford. Her focus on the molecular epidemiology of tuberculosis in San Francisco brought her to The Gambia, where she developed an interest in TB transmission and the M. tuberculosis complex member Mycobacterium africanum. After an MSc in epidemiology at the Netherlands Institute for Health Sciences and PhD at the University of Amsterdam, Dr. de Jong joined the Division of Infectious Diseases at New York University as Assistant Professor in 2007.
Since 2010 Dr. de Jong heads the Unit of Mycobacteriology at the Institute of Tropical Medicine. Besides tuberculosis, she studies Buruli Ulcer and leprosy, focusing on improved diagnostics and treatment, as well as molecular epidemiological studies on the impact of public health interventions to reduce transmission, for which she was supported by an ERC starting grant. Together with a very capable team she (co)supervises PhD students from different (endemic) countries.
Research lines
- Improved molecular (resistance) diagnostics for leprosy, Buruli ulcer, and tuberculosis
- Phylogeography, phylodynamics, and molecular epidemiology of M. ulcerans, M. tuberculosis, and M. leprae in the context of intervention studies
- Optimized treatment for M. tuberculosis
Education/Academic qualification
Medicine, PhD
Medicine, MD
Epidemiology, MSc
Fingerprint
Dive into the research topics where Bouke de Jong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Culturing from Tongue Swabs
Rigouts, L., de Jong, B., Hassane Harouna, S. & Janssens, N.
12/12/22 → 15/12/23
Project: Research Project
-
Omics Data Integration to Predict Drug Resistance in Mycobacterium tuberculosis
Snobre, J., de Jong, B. & Buyl, R.
27/04/22 → …
Project: PhD-project
-
TB/NTM Research Cluster
de Jong, B., Sengstake, S., Rigouts, L., Tzfadia, O., Ardizzoni, E., Lynen, L., Decroo, T., Hasker, E., Van Rie, A. & Janssens, N.
Fonds voor Wetenschappelijk Onderzoek
1/01/22 → 31/12/26
Project: Research Project
-
FA5 RDC_OC1: Strengthen research and education capacities in the partner institutes (INRB, CRSK, ESP) in DRC (Outcome 1) - Support to interruption of transmission of Human African Trypanosomiasis (HAT) by 2030 (Outcome 2)
Vanlerberghe, V., Verlé, P., Nicco, E., Van Cauwenberg, I., Everaert, R., Rosanas-Urgell, A., Mutsaers, M., de Jong, B., Van Den Abbeele, J., Dermauw, V., Ariën, K., Hauner, A., Monsieurs, P. & Van Bortel, W.
1/01/22 → 31/12/26
Project: Development project
-
Rapid diagnosis of Mycobacterium tuberculosis resistance, beyond rifampicin
Massou, F., de Jong, B., Rigouts, L., Affolabi, D. & Meehan, C. J.
1/01/22 → …
Project: PhD-project
Research output
-
Mycobacterium tuberculosis retains viability in RNAlater buffer but not in GTC-TCEP and DNA/RNA Shield
Krausser, L., Braet, S. M., Benaamar, Z., Van Dyck-Lippens, M., de Jong, B. C. & Rigouts, L., 1-Feb-2023, (E-pub ahead of print) In: Diagnostic Microbiology and Infectious Disease. 106, 1, p. 115905Research output: Contribution to journal › Article › peer-review
-
Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings
Van Deun, A., Bola, V., Lebeke, R., Kaswa, M., Hossain, M. A., Gumusboga, M., Torrea, G., De Jong, B. C., Rigouts, L. & Decroo, T., 2022, In: JAC-Antimicrobial Resistance. 4, 2, 9 p., dlac037.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
Balancing access to BPaLM regimens and risk of resistance
Van Rie, A., Walker, T. M., de Jong, B., Rupasinghe, P., Riviere, E., Gagneux, S., Supply, P., Dreyer, V., Niemann, S., Goig, G. A. & Cirillo, D. M., 2022, In: Lancet Infectious Diseases. 22, 10, p. 1411-1412 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Clinical standards for drug-susceptible pulmonary TB
Akkerman, O. W., Duarte, R., Tiberi, S., Schaaf, H. S., Lange, C., Alffenaar, J. W. C., Denholm, J., Carvalho, A. C. C., Bolhuis, M. S., Borisov, S., Bruchfeld, J., Cabibbe, A. M., Caminero, J. A., Carvalho, MRC., Chakaya, J., Centis, R., Dalcomo, M. P., Ambrosio, L. D., Dedicoat, M., Dheda, K. & 27 others, , 2022, In: International Journal of Tuberculosis and Lung Disease. 26, 7, p. 592-604 13 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: a retrospective cohort study
Souleymane, M. B., Decroo, T., Mamadou, S., Soumana, A., Lawan, I. M., Gagara-Issoufou, A., Adehossi, E., Ortuño-Gutiérrez, N., Lynen, L., Rigouts, L., de Jong, B. C., Van Deun, A. & Piubello, A., 2022, (E-pub ahead of print) In: International Health.Research output: Contribution to journal › A1: Web of Science-article › peer-review